Showing results (51-60 of 86) with videos related to
Sort By:
Pageof 9
Brachytherapy|January 6, 2026
Randomized trial of dose de-escalation in low-risk prostate cancer patients implanted with Pd-103Martin King, Grgur Mirić, Mutlay Sayan, et al.Prostate Cancer and Prostatic Diseases|September 11, 2025
Brachytherapy monotherapy for favorable and select unfavorable intermediate risk prostate cancerMartin King, Grgur Mirić, Robert Galbreath, et al.Advances in Radiation Oncology|July 13, 2026
Nonprostate Cancer Deaths Best Predict Long-Term Survival in Men Aged ≤59 Years Treated With Low Dose Rate Brachytherapy With or Without Supplemental Therapies: A Mandate for Health EnhancementPeter Orio, Grgur Mirić, Robert Galbreath, et al.IEEE Transactions on Medical Imaging|December 16, 2006
Semiautomatic 3-D prostate segmentation from TRUS images using spherical harmonicsIsmail B Tutar, Sayan D Pathak, Lixin Gong, et al.Medical Physics|November 19, 2025
Comparison of integrated biological effectiveness of eye plaques with 125I and 103Pd photon sources using equivalent uniform RBE-weighted doseYulun He, Kent Wallner, Jonathan J Chen, et al.BMC Geriatrics|December 16, 2025
Long-term prostate cancer survival outcomes including patterns of death in men >=75 years of age treated with low dose rate brachytherapyShalini Moningi, Grgur Mirić, Robert Galbreath, et al.Medical Physics|April 15, 2008
Seed-based transrectal ultrasound-fluoroscopy registration method for intraoperative dosimetry analysis of prostate brachytherapyIsmail B Tutar, Lixin Gong, Sreeram Narayanan, et al.Physics and Imaging in Radiation Oncology|March 4, 2022
Impact of lung block shape on cardiac dose for total body irradiationMallory C Glenn, Kent Wallner, Samuel M H Luk, et al.Journal of Applied Clinical Medical Physics|January 5, 2022
Effect of total body irradiation lung block parameters on lung doses using three-dimensional dosimetrySamuel M H Luk, Kent Wallner, Mallory C Glenn, et al.Urology|July 9, 2002
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesityGregory S Merrick, Wayne M Butler, Kent Wallner, et al.Pageof 9